Department of Ophthalmology, Ege University Medical Faculty Hospital, 35100, Izmir, Turkey.
Department of Public Health, Katip Celebi University School of Medicine, Izmir, Turkey.
Int Ophthalmol. 2024 Aug 2;44(1):337. doi: 10.1007/s10792-024-03269-5.
To evaluate limbal graft transplantation success in pediatric patients with chemical injury-induced limbal stem cell deficiency (LSCD) using the 'LSCD Working Group' staging system.
Medical records of 11 eyes of 11 children who underwent limbal graft transplantation (limbal autograft/limbal allograft) were included. Surgical success was defined as improvement in the post-operative 1st year LSCD stage.
The mean age was 12 ± 5 (4-17) years. Causative agent was alkaline in 4(36.4%) and acid in 3(27.2%) patients. Limbal autograft was performed in 9 (81.8%) eyes with unilateral LSCD, and allograft transplantation was performed in 2 (18.2%) eyes with bilateral LSCD. The mean follow-up time was 33.89 ± 30.73 (12-102.33) months. The overall limbal graft transplantation success rate was 72.7%. Among 9 patients who receive limbal autograft, 8 had improvement in post-operative LSCD stage, 1 had stable LSCD stage. Of the 2 patients who receive limbal allograft, post-operative LSCD stage remained the same in 1 and worsened in 1 patient. The mean time between injury and the surgery was 30.47 ± 30.08 (7-108.47) months. Penetrating keratoplasty was performed in 3 (27.2%) of 11 patients following limbal graft transplantation.
Management of LSCD in children is challenging and appears to be somewhat different from that of adults. Limited data in the literature indicate that cultivated or simple limbal epithelial transplantations (CLET/SLET) are primarily preferred in children. Although the tendency to take small tissue from the healthy eye is noteworthy, conventional limbal allograft and autograft transplantations also show promising results without any further complications in at least 1 year follow-up period.
使用“眼表疾病干细胞研究协作组(LSCD 工作组)”分期系统评估儿童化学伤相关角膜缘干细胞缺乏症(LSCD)患者行角膜缘移植的成功率。
纳入 11 例(11 只眼)患儿行角膜缘移植(自体或同种异体)的病历资料。将术后 1 年时 LSCD 分期改善定义为手术成功。
患儿平均年龄为 12±5(4-17)岁,碱性化学伤 4 例(36.4%),酸性化学伤 3 例(27.2%)。9 只眼(81.8%)行单侧 LSCD 自体角膜缘移植,2 只眼(18.2%)行双侧 LSCD 同种异体角膜缘移植。平均随访时间为 33.89±30.73(12-102.33)个月。总的角膜缘移植成功率为 72.7%。9 例行自体角膜缘移植的患者中,8 例术后 LSCD 分期改善,1 例稳定。2 例行同种异体角膜缘移植的患者中,1 例术后 LSCD 分期无变化,1 例恶化。外伤至手术的时间为 30.47±30.08(7-108.47)个月。11 例患者中有 3 例(27.2%)在角膜缘移植术后行穿透性角膜移植。
儿童 LSCD 的治疗颇具挑战,与成人有所不同。文献中有限的数据表明,儿童患者主要首选培养或简单的角膜缘上皮移植(CLET/SLET)。虽然从健眼取小组织的倾向值得注意,但在至少 1 年的随访中,传统的同种异体和自体角膜缘移植也取得了良好的效果,且无进一步的并发症。